Trimethoprim Sulfamethoxazole
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of North Carolina, Chapel Hill
Overview
Trimethoprim Sulfamethoxazole is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Trimethoprim Sulfamethoxazole clinical trials
Explore related
Medical disclaimer. This page summarizes research about Trimethoprim Sulfamethoxazole for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.